Viva Biotech Announces 2024 Interim Results With Profit Growth
29 Aug 2024 //
PR NEWSWIRE
Latest Updates of Viva Biotech`s Portfolio Companies
06 Aug 2024 //
PR NEWSWIRE
Latest Updates of Viva Biotech`s Portfolio Companies
12 Jun 2024 //
PR NEWSWIRE
Latest Updates of Viva Biotech`s Portfolio Companies
06 Mar 2024 //
PR NEWSWIRE
Riparian Announces Agreement and Research Agreement with Pfizer
20 Jul 2023 //
PR NEWSWIRE
Viva Announced Investors with an Investment of Approximately US$ 210 Million
16 Jun 2023 //
PR NEWSWIRE
Viva Biotech Attended SAPA-China
12 Apr 2023 //
PR NEWSWIRE
Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry
05 Oct 2021 //
FIERCEBIOTECH
Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly
10 May 2021 //
PRNEWSWIRE
Viva Biotech to acquire small molecule drug discovery contract organisation
21 Sep 2020 //
PHARMABIZ
Viva Biotech And Synthesis Enters A Strategic Acquisition Agreement
20 Sep 2020 //
ASIAONE
Viva Biotech`s Dogma Therapeutics in Acquisition Agreement with AstraZeneca
16 Sep 2020 //
PRNEWSWIRE
Viva Biotech acquires major stake in Chinese CDMO
13 Aug 2020 //
BIOSPECTRUMASIA